Immuno-Biological Laboratories Co (TSE:4570) Forward Dividend Yield %: 0.79% (As of Jun. 30, 2026)


TSE:4570 Immuno-Biological Laboratories Co Ltd TSE:4570
59 GF Score
Price 円963.00
GF Value 円576.66
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Immuno-Biological Laboratories Co Forward Dividend Yield %?

Immuno-Biological Laboratories Co TSE:4570 +0.84% 59 Forward Dividend Yield % is 0.79% as of Jun. 30, 2026. GuruFocus rates TSE:4570 with a GF Score™ of 59/100 and a GF Value™ of 円576.66 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 145 Biotechnology companies, Immuno-Biological Laboratories Co ranks worse than 73.1% on this metric.

As of today (2026-06-30), the Forward Annual Dividend Yield of Immuno-Biological Laboratories Co is 0.79%.

As of today (2026-06-30), the Trailing Annual Dividend Yield of Immuno-Biological Laboratories Co is 0.63%.

TSE:4570's Forward Dividend Yield % is ranked worse than
73.1% of 145 companies
in the Biotechnology industry
Industry Median: 1.52 vs TSE:4570: 0.79

Immuno-Biological Laboratories Co's Dividends per Share for the six months ended in Mar. 2026 was 円6.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Immuno-Biological Laboratories Co  (TSE:4570) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Immuno-Biological Laboratories Co Forward Dividend Yield % Related Terms


TSE:4570 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immuno-Biological Laboratories Co Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's Forward Dividend Yield % falls into.


TSE:4570
59GF Score
Immuno-Biological Laboratories Co Ltd TSE:4570
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immuno-Biological Laboratories Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Immuno-Biological Laboratories Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
JPY 6.0000002026-03-302026-03-312026-06-26Cash Dividendsemi-annuallyJPY:JPY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Immuno-Biological Laboratories Co's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=12/963.00
=1.25 %

Current Share Price is 円963.00.
Immuno-Biological Laboratories Co's Dividends per Share for the forward twelve months is calculated as 円6 * 2 = 円12.

Immuno-Biological Laboratories Co's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=6/963.00
=0.62 %

Current Share Price is 円963.00.
Immuno-Biological Laboratories Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is 円6.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 0.79% mean?
Immuno-Biological Laboratories Co (TSE:4570) has a Forward Dividend Yield % of 0.79% as of Jun. 30, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Immuno-Biological Laboratories Co and its competitors. According to the industry distribution chart, Immuno-Biological Laboratories Co ranks #106 out of 145 companies in the Biotechnology industry, placing it in the top 73.1%.
Is Immuno-Biological Laboratories Co's Forward Dividend Yield % too high?
Immuno-Biological Laboratories Co's current Forward Dividend Yield % is 0.79%. The Biotechnology industry median Forward Dividend Yield % is 1.52. Immuno-Biological Laboratories Co's value of 0.79% is 48% below this industry median. Based on the distribution chart, Immuno-Biological Laboratories Co ranks #106 out of 145 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Immuno-Biological Laboratories Co has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Immuno-Biological Laboratories Co's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Immuno-Biological Laboratories Co ranks #106 out of 145 companies for Forward Dividend Yield %. This places Immuno-Biological Laboratories Co in the lower half of its industry. The industry median Forward Dividend Yield % is 1.52. Immuno-Biological Laboratories Co's value of 0.79% is 48% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.52, based on 145 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Immuno-Biological Laboratories Co's current Forward Dividend Yield % of 0.79% is 48% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Immuno-Biological Laboratories Co and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Immuno-Biological Laboratories Co's current Forward Dividend Yield % is 0.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immuno-Biological Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, Immuno-Biological Laboratories Co (TSE:4570) is currently considered Significantly Overvalued. The stock's GF Value™ is 円576.66, compared to a current price of 円963.00 — trading 67% above its estimated fair value. The current Forward Dividend Yield % is 0.79% and 48% below the Biotechnology industry median of 1.52. Immuno-Biological Laboratories Co's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Immuno-Biological Laboratories Co (TSE:4570), the current Forward Dividend Yield % is 0.79% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Immuno-Biological Laboratories Co (TSE:4570) Overvalued in 2026?

Based on GuruFocus' analysis, Immuno-Biological Laboratories Co stock appears to be overvalued. The current stock price of 円963.00 is trading 67% above its estimated GF Value™ of 円576.66. GuruFocus considers Immuno-Biological Laboratories Co to be Significantly Overvalued.

Key valuation signals for TSE:4570:

  • Forward Dividend Yield %: 0.79%
  • GF Value™: 円576.66 vs. price of 円963.00 (67% above fair value)
  • GF Score™: 59/100 with 2 warning signs
  • Industry Position: 48% below the Biotechnology median (#106 of 145)

No single metric tells the full story. See the TSE:4570 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Immuno-Biological Laboratories Co Business Description

Address 1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005
Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.
59GF Score

Get the complete analysis for TSE:4570

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円963.00
Price
円576.66
GF Value